Tyrosine Kinase Inhibitor Induced Isolated Pericardial Effusion

Long-term therapy with tyrosine kinase inhibitors (TKI) has resulted in improved outcomes for patients suffering from Bcr-Abl fusion protein-harboring leukemias. As a result, a growing population of patients on TKI therapy present to their primary care providers. In this case, we report on the case...

Descripción completa

Detalles Bibliográficos
Autores principales: Agrawal, Vineet, Christenson, Eric S., Showel, Margaret M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2015
Materias:
Published online: February, 2015
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361914/
https://www.ncbi.nlm.nih.gov/pubmed/25848358
http://dx.doi.org/10.1159/000375484

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361914/
https://www.ncbi.nlm.nih.gov/pubmed/25848358
http://dx.doi.org/10.1159/000375484

Ejemplares similares